coronaviru
diseas
caus
novel
sever
acut
respiratori
syndrom
coronaviru
acut
respiratori
diseas
lead
respiratori
failur
death
previou
epidem
novel
coronaviru
diseas
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
associ
similar
clinic
featur
outcom
one
might
anticip
patient
chronic
respiratori
diseas
particularli
chronic
obstruct
pulmonari
diseas
copd
asthma
would
increas
risk
infect
sever
present
howev
strike
diseas
appear
underrepres
comorbid
report
patient
compar
global
burden
diseas
estim
preval
condit
gener
popul
tabl
similar
pattern
seen
sar
contrast
preval
diabet
patient
sar
high
higher
estim
nation
preval
might
expect
lower
report
preval
asthma
copd
patient
diagnos
might
due
one
number
factor
first
possibl
contrast
diagnosi
diabet
substanti
underdiagnosi
poor
recognit
chronic
respiratori
diseas
patient
particularli
china
howev
seem
unlik
recent
data
march
itali
among
patient
die
mean
age
year
diabet
report
patient
copd
list
comorbid
patient
similarli
provision
data
usa
march
show
chronic
respiratori
diseas
diabet
comorbid
patient
respect
compar
global
burden
diseas
figur
popul
whole
chronic
respiratori
diseas
diabet
howev
data
base
patient
report
second
possibl
chronic
respiratori
diseas
protect
perhap
differ
immun
respons
elicit
chronic
diseas
howev
theori
support
find
among
copd
comorbid
mortal
increas
would
otherwis
expect
third
possibl
therapi
use
patient
chronic
respiratori
diseas
reduc
risk
infect
develop
symptom
lead
diagnosi
import
note
around
half
patient
copd
china
take
treatment
standard
europ
north
america
peopl
china
asthma
use
inhal
corticosteroid
furthermor
invitro
model
inhal
corticosteroid
alon
combin
bronchodil
shown
suppress
coronaviru
replic
cytokin
product
lowqual
evid
also
exist
case
seri
japan
improv
seen
three
patient
requir
oxygen
ventilatori
support
given
inhal
ciclesonid
howev
control
group
use
known
whether
patient
would
improv
spontan
yet
possibl
inhal
corticosteroid
might
prevent
least
partli
develop
symptomat
infect
sever
present
ignor
contrast
systemat
review
use
system
corticosteroid
treat
sar
establish
show
benefit
possibl
harm
potenti
benefit
harm
inhal
corticosteroid
treatment
peopl
risk
infect
patient
unclear
present
chang
treatment
manag
chronic
respiratori
condit
includ
copd
asthma
consid
stage
howev
collect
accur
data
comorbid
previou
therapi
patient
essenti
understand
risk
factor
becom
infect
develop
symptom
diagnos
well
enabl
answer
question
possibl
benefit
harm
therapi
asthma
copd
pandem
could
achiev
use
standard
dataset
advoc
includ
inform
presenc
sever
comorbid
medic
taken
time
infect
dmgh
receiv
person
fee
astrazeneca
boehring
ingelheim
chiesi
glaxosmithklin
novarti
pfizer
sanofi
nonfinanci
support
boehring
ingelheim
novarti
outsid
submit
work
rf
receiv
grant
glaxosmithklin
menarini
outsid
submit
work
aa
receiv
grant
astrazeneca
glaxosmithklin
menarini
person
fee
astrazeneca
chiesi
glaxosmithklin
menarini
outsid
submit
work
os
jrb
declar
compet
interest
